Drug
Bupivacaine Tts
Bupivacaine Tts: highest development phase Phase 2, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bupivacaine TTS (Bupivacaine Patch) NCT01096966 | Phase 2 | Chronic Low Back Pain |
Latest
No recent events.
Follow Bupivacaine Tts on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.